1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Inhalable Insulin
1.2.3 Oral Insulin
1.2.4 Insulin Patches
1.2.5 CGM Systems
1.2.6 Artificial Pancreas
1.3 Market by Application
1.3.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Diagnostic/Clinics
1.3.3 ICUs
1.3.4 Home Healthcare
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Perspective (2017-2028)
2.2 Next Generation Diabetes Therapy and Drug Delivery Growth Trends by Region
2.2.1 Next Generation Diabetes Therapy and Drug Delivery Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Next Generation Diabetes Therapy and Drug Delivery Historic Market Size by Region (2017-2022)
2.2.3 Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Region (2023-2028)
2.3 Next Generation Diabetes Therapy and Drug Delivery Market Dynamics
2.3.1 Next Generation Diabetes Therapy and Drug Delivery Industry Trends
2.3.2 Next Generation Diabetes Therapy and Drug Delivery Market Drivers
2.3.3 Next Generation Diabetes Therapy and Drug Delivery Market Challenges
2.3.4 Next Generation Diabetes Therapy and Drug Delivery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Next Generation Diabetes Therapy and Drug Delivery Players by Revenue
3.1.1 Global Top Next Generation Diabetes Therapy and Drug Delivery Players by Revenue (2017-2022)
3.1.2 Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Players (2017-2022)
3.2 Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Next Generation Diabetes Therapy and Drug Delivery Revenue
3.4 Global Next Generation Diabetes Therapy and Drug Delivery Market Concentration Ratio
3.4.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Next Generation Diabetes Therapy and Drug Delivery Revenue in 2021
3.5 Next Generation Diabetes Therapy and Drug Delivery Key Players Head office and Area Served
3.6 Key Players Next Generation Diabetes Therapy and Drug Delivery Product Solution and Service
3.7 Date of Enter into Next Generation Diabetes Therapy and Drug Delivery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Next Generation Diabetes Therapy and Drug Delivery Breakdown Data by Type
4.1 Global Next Generation Diabetes Therapy and Drug Delivery Historic Market Size by Type (2017-2022)
4.2 Global Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Type (2023-2028)
5 Next Generation Diabetes Therapy and Drug Delivery Breakdown Data by Application
5.1 Global Next Generation Diabetes Therapy and Drug Delivery Historic Market Size by Application (2017-2022)
5.2 Global Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Next Generation Diabetes Therapy and Drug Delivery Market Size (2017-2028)
6.2 North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2017-2022)
6.3 North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size (2017-2028)
7.2 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2017-2022)
7.3 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size (2017-2028)
8.2 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2017-2022)
8.3 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size (2017-2028)
9.2 Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2017-2022)
9.3 Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Size (2017-2028)
10.2 Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2017-2022)
10.3 Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Detail
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Introduction
11.1.4 Johnson & Johnson Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
11.1.5 Johnson & Johnson Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Detail
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Introduction
11.2.4 Abbott Laboratories Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
11.2.5 Abbott Laboratories Recent Development
11.3 Medtronic
11.3.1 Medtronic Company Detail
11.3.2 Medtronic Business Overview
11.3.3 Medtronic Next Generation Diabetes Therapy and Drug Delivery Introduction
11.3.4 Medtronic Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
11.3.5 Medtronic Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Detail
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Next Generation Diabetes Therapy and Drug Delivery Introduction
11.4.4 Sanofi Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
11.4.5 Sanofi Recent Development
11.5 Novo Nordisk
11.5.1 Novo Nordisk Company Detail
11.5.2 Novo Nordisk Business Overview
11.5.3 Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Introduction
11.5.4 Novo Nordisk Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
11.5.5 Novo Nordisk Recent Development
11.6 MannKind Corporation
11.6.1 MannKind Corporation Company Detail
11.6.2 MannKind Corporation Business Overview
11.6.3 MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Introduction
11.6.4 MannKind Corporation Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
11.6.5 MannKind Corporation Recent Development
11.7 Enteris BioPharma
11.7.1 Enteris BioPharma Company Detail
11.7.2 Enteris BioPharma Business Overview
11.7.3 Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Introduction
11.7.4 Enteris BioPharma Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
11.7.5 Enteris BioPharma Recent Development
11.8 Dexcom
11.8.1 Dexcom Company Detail
11.8.2 Dexcom Business Overview
11.8.3 Dexcom Next Generation Diabetes Therapy and Drug Delivery Introduction
11.8.4 Dexcom Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
11.8.5 Dexcom Recent Development
11.9 Senseonics
11.9.1 Senseonics Company Detail
11.9.2 Senseonics Business Overview
11.9.3 Senseonics Next Generation Diabetes Therapy and Drug Delivery Introduction
11.9.4 Senseonics Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
11.9.5 Senseonics Recent Development
11.10 Medtech
11.10.1 Medtech Company Detail
11.10.2 Medtech Business Overview
11.10.3 Medtech Next Generation Diabetes Therapy and Drug Delivery Introduction
11.10.4 Medtech Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
11.10.5 Medtech Recent Development
11.11 Synertech
11.11.1 Synertech Company Detail
11.11.2 Synertech Business Overview
11.11.3 Synertech Next Generation Diabetes Therapy and Drug Delivery Introduction
11.11.4 Synertech Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
11.11.5 Synertech Recent Development
11.12 Zosano Pharma
11.12.1 Zosano Pharma Company Detail
11.12.2 Zosano Pharma Business Overview
11.12.3 Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Introduction
11.12.4 Zosano Pharma Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
11.12.5 Zosano Pharma Recent Development
11.13 Relmada Therapeutics
11.13.1 Relmada Therapeutics Company Detail
11.13.2 Relmada Therapeutics Business Overview
11.13.3 Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Introduction
11.13.4 Relmada Therapeutics Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
11.13.5 Relmada Therapeutics Recent Development
11.14 Eli Lilly and Company
11.14.1 Eli Lilly and Company Company Detail
11.14.2 Eli Lilly and Company Business Overview
11.14.3 Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Introduction
11.14.4 Eli Lilly and Company Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
11.14.5 Eli Lilly and Company Recent Development
11.15 Transdermal Specialties
11.15.1 Transdermal Specialties Company Detail
11.15.2 Transdermal Specialties Business Overview
11.15.3 Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Introduction
11.15.4 Transdermal Specialties Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
11.15.5 Transdermal Specialties Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
